Vir Biotechnology (VIR) News Today → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free VIR Stock Alerts $10.09 -0.01 (-0.10%) (As of 10:47 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCritical Review: Vir Biotechnology (NASDAQ:VIR) versus Aura Biosciences (NASDAQ:AURA)americanbankingnews.com - March 25 at 1:20 AMBillionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfoliofinance.yahoo.com - March 21 at 2:10 AMVir Biotechnology (NASDAQ:VIR) Trading Down 4.8%marketbeat.com - March 19 at 3:33 PMFrom Six Figures to Seven: 3 Biotech Stocks Set to Make Millionairesinvestorplace.com - March 19 at 2:58 PMHC Wainwright Reiterates "Buy" Rating for Vir Biotechnology (NASDAQ:VIR)americanbankingnews.com - March 19 at 2:32 AMVir Biotechnology (NASDAQ:VIR) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - March 18 at 6:32 PMHudson Bay Capital Management LP Buys 197,500 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - March 17 at 5:11 AMVIR Jul 2024 17.500 callca.finance.yahoo.com - March 16 at 7:21 AMAnalysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and IN8bio (INAB)markets.businessinsider.com - March 15 at 12:59 PMVir Biotechnology, Inc. (VIR)finance.yahoo.com - March 15 at 7:52 AMVir Biotechnology (NASDAQ:VIR) Trading Down 4.9%marketbeat.com - March 12 at 3:37 PMBuy Rating Affirmed for Vir Biotechnology on Promising HDV and HBV Programs and Strategic Market Positioningmarkets.businessinsider.com - March 11 at 7:24 AMGSA Capital Partners LLP Invests $1.10 Million in Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - March 10 at 7:48 AMSchonfeld Strategic Advisors LLC Raises Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - March 9 at 5:43 AMMaintaining Buy Rating on ONCY Amidst Promising Clinical Advancements and Partnership Potentialmarkets.businessinsider.com - March 8 at 6:31 PMVir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedulefinance.yahoo.com - March 5 at 11:13 AMVIR Oct 2024 20.000 callfinance.yahoo.com - February 29 at 8:31 AMVir Biotechnology: Making Progress In Hepatitis B And Hepatitis Deltaseekingalpha.com - February 28 at 12:51 AMVir Biotechnology (NASDAQ:VIR) Shares Down 2.7% After Insider Sellingmarketbeat.com - February 27 at 10:23 AMThese 2 Biotech Stocks Are Rising Against the Recent Small-Caps Downtrendrealmoney.thestreet.com - February 26 at 12:41 PM3 Highly Rated Biotech Stocks to Buy for 300% Gainsinvestorplace.com - February 26 at 6:55 AMOptimistic Outlook for Vir Biotechnology’s Clinical Programs and Financial Position Reinforces Buy Ratingmarkets.businessinsider.com - February 26 at 4:27 AMVir Biotechnology (VIR) Price Target Increased by 9.93% to 33.08msn.com - February 25 at 12:14 AMOptimistic Buy Rating on Vir Biotechnology Amidst Advancing HDV and HBV Programs and Upcoming Clinical Catalystsmarkets.businessinsider.com - February 23 at 5:49 PMStrong Buy Rating for Vir Biotechnology on Promising Hepatitis Pipeline and Market Leadership Potentialmarkets.businessinsider.com - February 23 at 5:49 PMQ4 2023 Vir Biotechnology Inc Earnings Callfinance.yahoo.com - February 23 at 5:49 PMVir Biotechnology (NASDAQ:VIR) Posts Quarterly Earnings Resultsmarketbeat.com - February 23 at 2:01 PMVir Biotechnology Shares Rise 14% on Terminated Collaboration with GSKmarketwatch.com - February 23 at 12:49 PMVir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 23 at 12:49 PMVir Biotechnology (NASDAQ:VIR) Trading 8.5% Higher on Strong Earningsmarketbeat.com - February 23 at 10:20 AMAlgert Global LLC Acquires New Shares in Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - February 23 at 9:42 AMVir Biotechnology to Participate in Upcoming Investor Healthcare Conferencesbusinesswire.com - February 23 at 8:05 AMVir Biotechnology Stock (NASDAQ:VIR), Short Interest Reportbenzinga.com - February 22 at 6:09 PMVir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 22 at 6:09 PMVir Biotechnology is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - February 22 at 8:08 AMVir, in midst of restructuring, loses its chief medical officerfinance.yahoo.com - February 21 at 5:56 PMVir Biotechnology Chief Medical Officer Phil Pang to Departmarketwatch.com - February 20 at 9:11 PMVir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officerfinance.yahoo.com - February 20 at 9:11 PMRafferty Asset Management LLC Acquires 213,477 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - February 19 at 7:24 AMVir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - February 19 at 1:54 AMVIR Mar 2024 15.000 callfinance.yahoo.com - February 18 at 5:37 PMVIR Mar 2024 7.500 putfinance.yahoo.com - February 18 at 5:37 PMVir Biotechnology, Inc. (NASDAQ:VIR) to Post FY2028 Earnings of ($0.39) Per Share, HC Wainwright Forecastsmarketbeat.com - February 16 at 10:32 AMVir Biotechnology, Inc. (NASDAQ:VIR) Forecasted to Earn Q1 2025 Earnings of ($0.98) Per Sharemarketbeat.com - February 15 at 8:33 AM3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Waveinvestorplace.com - February 14 at 3:45 PMVir Biotechnology (NASDAQ:VIR) Shares Up 8.4% Following Analyst Upgrademarketbeat.com - February 14 at 11:33 AMVir Biotechnology (NASDAQ:VIR) Price Target Increased to $110.00 by Analysts at HC Wainwrightmarketbeat.com - February 14 at 8:25 AMBarclays PLC Has $3.86 Million Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - February 12 at 4:36 AMVir Biotechnology, Inc. (NASDAQ:VIR) Shares Purchased by Jupiter Asset Management Ltd.marketbeat.com - February 10 at 8:39 AMLeerink Partnrs Comments on Vir Biotechnology, Inc.'s FY2026 Earnings (NASDAQ:VIR)marketbeat.com - February 8 at 8:54 AM Get Vir Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… VIR Media Mentions By Week VIR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VIR News Sentiment▼0.000.60▲Average Medical News Sentiment VIR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VIR Articles This Week▼24▲VIR Articles Average Week Get Vir Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADAP News ADMA News AUTL News FUSN News CRGX News FDMT News BCRX News SRRK News KYTX News TARS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VIR) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.